Top Abstract Purchase Related
Home
>
Node
>
Subnode

Combined delivery of an antiangiogenic protein (angiostatin) and an immunomodulatory gene (interleukin-12) in the treatment of murine cancer

Wilczyńska, U.; Kucharska, A.; Szary, J.; Szala, S.

Acta Biochimica Polonica 48(4): 1077-1084

2001

ISSN/ISBN: 0001-527X
PMID: 11995969
Document Number: 538285
We investigated the feasibility of a novel therapeutic approach to treat neoplastic diseases in mice. This novel strategy consists in delivering a protein (angiostatin) with strong antiangiogenic properties, followed by administration of the interleukin 12 gene that is strongly immunomodulatory and has also some antiangiogenic effects. When angiostatin-mediated antiangiogenic therapy was used in combination with intratumor delivery of the IL-12 gene (a strategy much safer than IL-12 protein administration), this produced a synergistic therapeutic effect.

Document emailed within 1 workday
Secure & encrypted payments

Nicolet, C.M.; Burkholder, J.K.; Gan, J.; Culp, J.; Kashmiri, S.V.; Schlom, J.; Yang, N.S.; Sondel, P.M. 1995: Expression of a tumor-reactive antibody-interleukin 2 fusion protein after in vivo particle-mediated gene delivery Cancer Gene Therapy 2(3): 161-170
Zhang, T.; Kazuyoshi, K.; Mahboob, H.Qureshi.; Tang, Y.; Atsushi, S. 2003: Combined therapy of interleukin-12 and interleukin-18 against Cryptococcus neoformans infection in a murine model Chinese Medical Journal 116(5): 669-672
Jia, C.-r.; Yang, S.-y.; Han, S.-y.; Sun, L. 2008: Adenovirus mediated angiostatin gene therapy for ovarian cancer: experiment with nude mice Zhonghua Yi Xue Za Zhi 88(31): 2204-2208
Sim, B.K.; O'Reilly, M.S.; Liang, H.; Fortier, A.H.; He, W.; Madsen, J.W.; Lapcevich, R.; Nacy, C.A. 1997: A recombinant human angiostatin protein inhibits experimental primary and metastatic cancer Cancer Research 57(7): 1329-1334
Farrar, W.L.; Ruscetti, F.W.; Young, H.A. 1985: 5-Azacytidine treatment of a murine cytotoxic T cell line alters interferon-gamma gene induction by interleukin 2 Journal of Immunology 135(3): 1551-1554
Li, H.; Gao, R.; Wu, M.; Fu, M.; Wu, K.; Yang, Y.; Wang, X.; Wang, Z.; Liu, S. 2004: Effects of entrapment of murine interleukin-2 gene with chitosan nanoparticles on expression of mIL-2 gene and on regulation of immune response in mice Sheng Wu Yi Xue Gong Cheng Xue Za Zhi 21(6): 947-952
Sznol, M.; Clark, J.W.; Smith, J.W.; Steis, R.G.; Urba, W.J.; Rubinstein, L.V.; VanderMolen, L.A.; Janik, J.; Sharfman, W.H.; Fenton, R.G. 1992: Pilot study of interleukin-2 and lymphokine-activated killer cells combined with immunomodulatory doses of chemotherapy and sequenced with interferon alfa-2a in patients with metastatic melanoma and renal cell carcinoma Journal of the National Cancer Institute 84(12): 929-937
Ju, D.; Cao, X.; Wang, B. 1998: Antitumor effect of combined therapy with adenovirus-mediated CD suicide gene and interleukin 2 gene transfer and its immunological mechanism Zhonghua Zhong Liu Za Zhi 20(2): 108-111
Zhou, B.; Han, D.-m.; Wang, T.; Wang, X.-d.; Fan, E.-z.; Liu, Z.-y. 2005: Effect of intranasal interleukin-12 gene therapy for allergic rhinitis in murine model Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 40(6): 444-448
Elhofy, A.; Bost, K.L. 1998: Limitations for purification of murine interleukin-18 when expressed as a fusion protein containing the FLAG peptide Biotechniques 25(3): 426-433
Yang, J.-h.; Fan, R.-f.; Qian, Q.-j.; You, T.-g.; Xue, H.-b.; Su, C.-q.; Cao, H.-f.; Wu, M.-c. 2003: Treatment of hepatocellular carcinoma by transfecting interleukin-12 and interleukin-2 fusion gene intrasplenically, an experimental study Zhonghua Yi Xue Za Zhi 83(9): 740-743
Neve, R.L.; Geller, A.I. 1995: A defective herpes simplex virus vector system for gene delivery into the brain: comparison with alternative gene delivery systems and usefulness for gene therapy Clinical Neuroscience 3(5): 262-267
Oshikawa, K.; Ishii, Y.; Hamamoto, T.; Sugiyama, Y.; Kitamura, S.; Kagawa, Y. 1999: Particle-mediated gene transfer of murine interleukin-12 cDNA suppresses the growth of Lewis lung carcinoma In Vivo 13(5): 397-402
Sun, W.; Jiang, Z.; Xiang, T.-X.; Tao, X.-H.; Huang, A.-L.; Wang, P.-L. 2009: Anti-tumor effect of eukaryotic expressing plasmid containing soluble tumor necrotic factor-related apoptosis inducing ligand combined with human angiostatin Kringle (1 - 3) genes on human gastric cancer xenografts in nude mice Zhonghua Yi Xue Za Zhi 89(12): 841-845
Bhat, N.; Perera, P.Y.; Carboni, J.M.; Blanco, J.; Golenbock, D.T.; Mayadas, T.N.; Vogel, S.N. 1999: Use of a photoactivatable taxol analogue to identify unique cellular targets in murine macrophages: identification of murine CD18 as a major taxol-binding protein and a role for Mac-1 in taxol-induced gene expression Journal of Immunology 162(12): 7335-7342
Suchin, K.Rebecca.; Cucchiara, A.J.; Gottleib, S.L.; Wolfe, J.T.; DeNardo, B.J.; Macey, W.H.; Bromley, P.G.; Vittorio, C.C.; Rook, A.H. 2002: Treatment of cutaneous T-cell lymphoma with combined immunomodulatory therapy: a 14-year experience at a single institution Archives of Dermatology 138(8): 1054-1060
Godambe, S.A.; Chaplin, D.D.; Takova, T.; Bellone, C.J. 1994: Upstream NFIL-6-like site located within a DNase I hypersensitivity region mediates LPS-induced transcription of the murine interleukin-1 beta gene Journal of Immunology 153(1): 143-152
Soltau, J.; Zirrgiebel, U.; Esser, N.; Schächtele, C.; Totzke, F.; Unger, C.; Merfort, I.; Drevs, J. 2008: Antitumoral and antiangiogenic efficacy of bisphosphonates in vitro and in a murine RENCA model Anticancer Research 28(2a): 933-941
Bubeník, J.; Símová, J.; Zeuthen, J.; Diamant, M.; Jandlová, T.; Bubeníková, D. 1994: Gene therapy of plasmacytoma: comparison of the therapeutic efficacy of tumour cells transduced with the interleukin-2, interleukin-4, or interleukin-6 genes Folia Biologica 40(1-2): 29-36
Jalbert, L.R.; Rosen, E.D.; Lissens, A.; Carmeliet, P.; Collen, D.; Castellino, F.J. 1998: Nucleotide structure and characterization of the murine gene encoding anticoagulant protein C Thrombosis and Haemostasis 79(2): 310-316